A panel of pharmaceutical industry experts discusses the advances in bioprocess filtration for improving virus removal and the key to economic large-scale filtration over the last decade.
GEN Roundup: Filters' Future Focuses on Functionality
This Genetic Engineering & Biotechnology News (GEN) article delivers input from bioprocess purification specialists involved in downstream biopharmaceutical production, as they discuss key advances in virus filtration over the last 10 years, with input on what is necessary for successful and economic large-scale filtration. GEN’s expert panel reviews filtration’s triumphs, tradeoffs, and future trials to come.
The panel includes Leesa McBurnie, Meissner Filtration Products’ Manager of Laboratory and Validation Services, as well as input from GE Healthcare Life Sciences, MilliporeSigma, Pall Life Sciences, Sartorius Stedim Biotech, and Spectrum Laboratories.